Loading…
The partnership will focus on the distribution of Xtant's allogeneic growth factor technology.
Xtant Medical Holdings, Inc. (XTNT) has entered into an exclusive partnership with Henry Schein's BioHorizons to distribute its allogeneic growth factor technology under the Prolifica Private Brand. This collaboration aims to enhance the reach and availability of Xtant's innovative medical solutions.
The partnership leverages BioHorizons' established distribution network to promote Xtant's Prolifica technology, which is designed to support bone and tissue regeneration. The agreement is expected to strengthen Xtant's market presence and expand its product offerings in the healthcare sector.
This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.